Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
Open | $283.120 |
Close | $279.730 |
Volume / Avg. | 294.125K / 209.089K |
Day Range | 276.240 - 285.270 |
52 Wk Range | 261.590 - 489.355 |
Market Cap | $7.977B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 25 |
Short Interest | 3.17% |
Days to Cover | 3.2 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Danaher (NYSE:DHR).
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Citigroup on Wednesday, April 3, 2024. The analyst firm set a price target for 365.00 expecting BIO to rise to within 12 months (a possible 30.48% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $279.73 last updated April 19, 2024 at 4:20 PM EDT.
A quarterly cash dividend of $0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on Invalid DateTime.
Bio-Rad Laboratories’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.